Liquidia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Liquidia 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LQDA

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC. 

CEO
Roger A. Jeffs
CEORoger A. Jeffs
Employees
216
Employees216
Headquarters
Morrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded
2004
Founded2004
Employees
216
Employees216

LQDA Key Statistics

Market cap
6.06B
Market cap6.06B
Price-Earnings ratio
50.33
Price-Earnings ratio50.33
Dividend yield
—
Dividend yield—
Average volume
1.01M
Average volume1.01M
High today
$69.21
High today$69.21
Low today
$66.89
Low today$66.89
Open price
$67.91
Open price$67.91
Volume
1.33M
Volume1.33M
52 Week high
$93.61
52 Week high$93.61
52 Week low
$21.15
52 Week low$21.15

Stock Snapshot

The current Liquidia(LQDA) stock price is $66.89, with a market capitalization of 6.06B. The stock trades at a price-to-earnings (P/E) ratio of 50.33.

On 2026-09-08, Liquidia(LQDA) stock moved within a range of $66.89 to $69.21. With shares now at $66.89, the stock is trading 0.0% above its intraday low and -3.4% below the session's peak.

Trading activity shows a volume of 1.33M, compared to an average daily volume of 1.01M.

Over the past 52 weeks, Liquidia(LQDA) stock has traded between a high of $93.61 and a low of $21.15.

Over the past 52 weeks, Liquidia(LQDA) stock has traded between a high of $93.61 and a low of $21.15.

LQDA News

CNN 5d
symbol__ Stock Quote Price and Forecast - CNN

...

symbol__ Stock Quote Price and Forecast - CNN
TipRanks 5d
Liquidia Gains FDA Fast Track for YUTREPIA in Raynaud’s

Liquidia Technologies ( (LQDA) ) has provided an announcement. On September 3, 2026, Liquidia Corporation announced that the U.S. Food and Drug Administration...

TipRanks 5d
Liquidia granted Fast Track designation to Yutrepia inhalation powder

Liquidia (LQDA) announced that the FDA has granted Fast Track designation to Yutrepia inhalation powder for the treatment of Raynaud’s phenomenon associated wit...

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

More LQDA News

Simply Wall St 5d
Liquidia Could Be 4% Undervalued Following New Pulmonary Hypertension Data

Liquidia (LQDA) stock is in focus after the company announced new data presentations on its inhaled treprostinil programs at the European Respiratory Society 20...

Liquidia Could Be 4% Undervalued Following New Pulmonary Hypertension Data

People also own

Based on the portfolios of people who own LQDA. This list is generated using Robinhood data, and it’s not a recommendation.
Rocket Lab Corporation
IonQ
Nebius Group
Micron Technology
Sandisk Corporation
Bloom Energy

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.